Physician

David Ian Weiss, MD

According to 2025 Medicare claims, David Weiss, MD (NPI: 1851431159) practices rheumatology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is ARTHRITIS ASSOCIATES, PLLC (NPI: 1588619167; TIN: 640919705) and primary practice location at 39402-8557. Weiss is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Weiss' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 345 traditional Medicare patients, billed 58,446 HCPCS/CPT codes, and received $438,763 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,976 prescription claims across 343 beneficiaries totaling $2,319,677 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2021 DME data shows 32 claims. Open Payments data shows 98 records totaling $19,501. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,416,550 and ending at $2,319,677. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,363 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	653	35,300	$885,558
2016	651	63,607	$1,203,996
2017	606	58,709	$1,043,960
2018	632	57,903	$1,050,236
2019	512	65,092	$961,727
2020	453	62,603	$1,020,863
2021	465	93,795	$1,298,171
2022	358	74,455	$885,569
2023	314	68,589	$776,431
2024	345	58,446	$438,763

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	410	4,589	$1,416,550
2016	483	5,263	$2,220,840
2017	508	5,461	$2,927,399
2018	474	4,846	$2,636,664
2019	416	4,031	$2,164,475
2020	407	3,862	$2,731,766
2021	384	3,631	$2,172,698
2022	307	2,538	$1,514,200
2023	264	2,440	$1,694,814
2024	343	2,976	$2,319,677

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	104	129	$76,070
2016	109	111	$104,518
2017	132	170	$114,540
2018	80	91	$88,328
2019	51	51	$53,982
2020	32	32	$34,950
2021	31	32	$21,514
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	560	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	130	229	$59
96372	Injection of drug or substance under skin or into muscle	201	509	$10
36415	Insertion of needle into vein for collection of blood sample	163	242	$9
J1885	Injection, ketorolac tromethamine, per 15 mg	140	898	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	60	1,671	$585,666
Rinvoq	Upadacitinib	65	1,950	$424,897
Enbrel Sureclick	Etanercept	45	1,260	$338,389
Enbrel Mini	Etanercept	40	1,149	$303,571
Humira(Cf)	Adalimumab	15	420	$183,727

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	91	$2,082	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	7	$17,419	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Ian Weiss, MD?

Tedicare shows public-source Medicare data for David Ian Weiss, MD (NPI 1851431159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Ian Weiss, MD have ACO affiliation data?

David Ian Weiss, MD is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to David Ian Weiss, MD?

David Ian Weiss, MD is linked to ARTHRITIS ASSOCIATES, PLLC (billing NPI 1588619167) in the available physician profile data.

Does David Ian Weiss, MD have Open Payments data?

David Ian Weiss, MD has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.